Reitan Colleen F, a director at Alnylam Pharmaceuticals ($ALNY), sold shares on the open market 17 times over the past year, totaling 8.4 million dollars. Her most recent sale occurred on September 9, 2025. These $ALNY insider sales rank 1287th among 11,678 individual insiders, below the average sale value of 8.6 million dollars and 6 transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 823 | $472.82 | 7,580.0000 | 127,651,000 | 9.79% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 951 | $474.85 | 5,791.0000 | 127,651,000 | 14.11% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 972 | $476.31 | 4,819.0000 | 127,651,000 | 16.78% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 1183 | $477.47 | 3,636.0000 | 127,651,000 | 24.55% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 1450 | $478.67 | 2,186.0000 | 127,651,000 | 39.88% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | M | Stock Option (right to buy) | 18000 | $0.00 | 0.0000 | 127,651,000 | 100.00% | 0.01% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 838 | $474.22 | 6,742.0000 | 127,651,000 | 11.06% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 25 | $480.98 | 775.0000 | 127,651,000 | 3.13% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 1386 | $479.55 | 800.0000 | 127,651,000 | 63.40% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | M | Common Stock | 18000 | $100.65 | 18,775.0000 | 127,651,000 | 2322.58% | 0.01% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 1645 | $457.44 | 17,130.0000 | 127,651,000 | 8.76% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 1888 | $458.86 | 15,242.0000 | 127,651,000 | 11.02% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 1403 | $459.73 | 13,839.0000 | 127,651,000 | 9.20% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 473 | $460.71 | 13,366.0000 | 127,651,000 | 3.42% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 2290 | $461.92 | 11,076.0000 | 127,651,000 | 17.13% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 1652 | $463.00 | 9,424.0000 | 127,651,000 | 14.92% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 799 | $464.36 | 8,625.0000 | 127,651,000 | 8.48% | 0.00% |
| Sept. 9, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 222 | $471.25 | 8,403.0000 | 127,651,000 | 2.57% | 0.00% |
| June 5, 2025 | MYRIAD GENETICS INC | $MYGN | Reitan Colleen F | Director | A | Common Stock | 49796 | $0.00 | 92,329.0000 | 91,309,064 | 117.08% | 0.05% |
| Aug. 29, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | P | Common Stock | 32 | $286.00 | 32.0000 | 124,906,000 | 9999.99% | 0.00% |
| Oct. 17, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | P | Common Stock | 4 | $302.67 | 36.0000 | 128,590,000 | 12.50% | 0.00% |
| April 16, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | S | Common Stock | 36 | $232.86 | 0.0000 | 127,651,000 | 100.00% | 0.00% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | A | Common Stock | 775 | $0.00 | 775.0000 | 127,651,000 | 9999.99% | 0.00% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | A | Stock Option (right to buy) | 1558 | $0.00 | 1,558.0000 | 127,651,000 | 9999.99% | 0.00% |
| Sept. 3, 2024 | MYRIAD GENETICS INC | $MYGN | Reitan Colleen F | Director | S | Common Stock | 46012 | $27.95 | 42,533.0000 | 0 | 51.96% | 0.00% |
| June 6, 2024 | MYRIAD GENETICS INC | $MYGN | Reitan Colleen F | Director | A | Common Stock | 15695 | $0.00 | 88,545.0000 | 0 | 21.54% | 0.00% |
| May 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Reitan Colleen F | Director | A | Stock Option (right to buy) | 5228 | $0.00 | 5,228.0000 | 124,906,000 | 9999.99% | 0.00% |
| June 1, 2023 | MYRIAD GENETICS INC | $MYGN | Reitan Colleen F | Director | A | Common Stock | 15151 | $0.00 | 72,850.0000 | 0 | 26.26% | 0.00% |